USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: CORSOLUTIONS, LLC
City: GROTON
State: NY
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,047,550.00 3
SBIR Phase II $1,600,000.00 1

Award List:

Plug-and-Play, Sensor-based, NanoLC/ESI Technology for Proteomics and Glycomics

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $400,000.00
Abstract:
DESCRIPTION (provided by applicant): Conventional nano-liquid chromatography electrospray mass spectrometry (nanoLC/ESI/MS or nanoLC/MS) is a challenging technique to perform, requiring a highly proficient user, and consequently, this powerful technique is alarmingly underutilized. The difficulty… More

Automated Manufacturing of High Performance Nanofluidic Separation Devices

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Colleen K. Vanpelt
Award Amount: $379,836.00
Abstract:
DESCRIPTION (provided by applicant): Nano-liquid chromatography (nanoLC) can resolve highly complex, otherwise intractable biological mixtures, and offer high sensitivity due to its enhanced resolving power. As a result when coupled to mass spectrometry, n anoLC can address complex proteomic… More

Plug-and-Play, Sensor-based, NanoLC/ESI Technology for Proteomics and Glycomics

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Colleen K. Van pelt – 607-533-4885
Award Amount: $1,600,000.00
Abstract:
DESCRIPTION (provided by applicant): Nano-liquid chromatography is a desirable technique because when coupled with mass spectrometry it can identify many of the components of a very complex proteomic or glycomic sample including subtle chemical variationswithin the sample, and can also obtain… More

A Novel Thioredoxin Mimetic Prodrug for Prevention of Bronchopulmonary Dysplasia

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Colleen K. Van pelt – 607-533-4885
Award Amount: $267,714.00
Abstract:
DESCRIPTION (provided by applicant): The merging of cell culture and microfluidic technology has resulted in improved in vitro models for toxicity studies, drug development, and biomedical research. The reason for which microfluidic approaches provide a more accurate in vitro model of in vivo… More